Medical diagnostic device with enough-sample indicator

• US 6,261,519 B1
• Filed: 07/16/1999
• Issued: 07/17/2001
• Est. Priority Date: 07/20/1998
• Status: Expired due to Term

• Current Assignee: Cilag Gmbh International (Johnson & Johnson)
• Original Assignee: Lifescan Incorporated (Duv Holding Corporation)
• Inventors: Cizdziel, Philip John, Zheng, Xiang Jennifer, Harding, Ian A., Shartle, Robert Justice
• Primary Examiner(s): ALEXANDER, LYLE
• Application Number:
  US09/356,248
• Time in Patent Office: 732 Days
• Field of Search: 422/56, 422/58, 422/61, 422/82.05, 422/100, 422/102, 422/103, 436/164, 436/165, 436/169, 436/171, 436/172, 436/177, 436/178, 436/69
• US Class Current: 422/417
• CPC Class Codes: B01L 2200/0621 Control of the sequence of chambers filled or emptied
• CPC Class Codes: B01L 2200/12 Specific details about manufacturing devices
• CPC Class Codes: B01L 2300/0681 Filter
• CPC Class Codes: B01L 2300/0822 Slides
• CPC Class Codes: B01L 2300/0825 Test strips
• CPC Class Codes: B01L 2300/0864 comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
• CPC Class Codes: B01L 2300/087 Multiple sequential chambers
• CPC Class Codes: B01L 2300/0887 Laminated structure
• CPC Class Codes: B01L 2400/0481 squeezing of channels or chambers
• CPC Class Codes: B01L 2400/0688 surface tension valves, capillary stop, capillary break
• CPC Class Codes: B01L 3/50273 characterised by the means or forces applied to move the fluids micropumps F04B19/006, of the membrane type F04B43/043
• CPC Class Codes: G01N 33/4905 Determining clotting time of blood by chemical methods G01N33/86, C12Q1/54
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: Y10T 436/25375 Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
• CPC Class Codes: Y10T 436/255 including use of a solid sorbent, semipermeable membrane, or liquid extraction

Abstract

A fluidic medical diagnostic device permits measurement of analyte concentration or a property of a biological fluid, particularly the coagulation time of blood. The device has at one end a sample port for introducing a sample and at the other end a bladder for drawing the sample to a measurement area. A first channel carries the sample from the sample port to the measurement area, and a stop junction, between the measurement area and bladder, halts the sample flow. A second channel, which runs from the first channel to an edge of the device, determines whether the sample volume is sufficient to permit an accurate measurement. The desired measurement can be made by placing the device into a meter, which measures a physical property of the sample, typically optical transmittance, after it has interacted with one or more reagents on the device.

Claims

1. A fluidic diagnostic device for measuring an analyte concentration or property of a biological fluid, comprising

a first layer and second layer, at least one of which has a resilient region over at least a part of its area, separated by an intermediate layer, in which cutouts in the intermediate layer form, with the first and second layers,

a) a sample port for introducing a sample of the biological fluid into the device;

b) a measurement area in which a physical parameter of the sample is measured and related to the analyte concentration or property of the fluid;

c) a first channel, having a first end and a second end, to provide a fluidic path from the sample port at the first end through the measurement area;

d) a bladder, at the second end of the first channel, comprising at least a part of the resilient region in at least the first or second layer and having a volume that is at least about equal to the combined volume of the measurement area and first channel;

e) a stop junction in the first channel between the measurement area and bladder that comprises a co-aligned through-hole in at least the first or second layer, the through-hole being overlaid with a third layer; and

f) a second channel having a first end in fluid communication with the first channel at a first point between the sample port and measurement area and a second end vented, in which

(i) at least the first or second layer has a transparent section at a predetermined second point adjoining the second channel and

(ii) the volume of the part of the second channel lying between the first and second points is at least about equal to the volume of the measurement area.

2. The device of claim 1 in which the physical parameter of the sample undergoes a change in the measurement area.

3. The device of claim 1 in which the sample port includes a reactant to react with the sample.

4. The device of claim 3 in which the reactant in the sample port is a denaturant/oxidant.

5. The device of claim 1 in which the second channel includes a reactant to react with a sample drawn into it.

6. The device of claim 5 in which the reactant in the second channel comprises an antibody latex.

7. The device of claim 1 in which the sample port comprises co-aligned through-holes in the first and intermediate layers.

8. The device of claim 1 in which the stop junction further comprises a second through-hole aligned with the first through-hole, the second through-hole being overlaid with a fourth layer.

9. The device of claim 1, further comprising a bypass channel, to provide an additional path from the first channel to the bladder, without traversing the measurement area and stop junction.

10. The device of claim 1 in which at least the first or second layer is substantially transparent adjoining the measurement area and the physical property that is measured is optical transmission through the measurement area.

11. The device of claim 1 further comprising a reflective surface adjoining the measurement area.

12. The device of claim 1 in which the biological fluid is whole blood and the property being measured is prothrombin time.

13. The device of claim 1 in which the measurement area comprises a composition that facilitates blood clotting.

14. The device of claim 13 in which the composition comprises thromboplastin.

15. The device of claim 1 further comprising a filter adjoining the sample port for filtering the biological fluid being introduced into the sample port.

16. The device of claim 15 in which the filter comprises an anisotropic membrane.

17. The device of claim 16 in which the filter material is polysulfone.

18. The device of claim 1 in which the volume of the part of the second channel lying between the first and second points is at least about equal to the combined volume of the measurement area and the volume of the part of the first channel lying between the first point and the measurement area.

19. The device of claim 1 further comprising a bypass channel from the first channel to the bladder and at least one alternate fluidic path from the first channel to the bladder, each such alternate path including a corresponding measurement area and stop junction.